Tilray Brands, Inc.

TLRY ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item May 2026 Feb 2026 Nov 2025 Aug 2025 May 2025 Feb 2025 Nov 2024 Aug 2024
Revenue $281.7M $206.7M $217.5M $209.5M $224.5M $185.8M $211.0M $200.0M
Cost of Revenue $191.2M $151.8M $160.0M $152.0M $156.9M $133.8M $149.7M $140.3M
Gross Profit $90.5M $55.0M $57.5M $57.5M $67.6M $52.0M $61.2M $59.7M
Gross Margin 32.1% 26.6% 26.4% 27.4% 30.1% 28.0% 29.0% 29.8%
Operating Expenses
Research & Development $180.0K $62.0K $78.0K $41.0K $34.0K $85.0K $60.0K $105.0K
SG&A Expense $61.2M $50.2M $51.2M $41.1M $38.0M $39.2M $46.0M $44.1M
Operating Income $-16.5M $-26.4M $-22.3M $2.1M $-1.44B $-759.9M $-42.2M $-36.6M
Operating Margin -5.8% -12.8% -10.2% 1.0% -643.1% -409.0% -20.0% -18.3%
Interest Expense
Pretax Income $-24.1M $-23.3M $-40.0M $-772.0K $-1.39B $-792.3M $-83.2M $-33.8M
Income Tax Expense $13.9M $2.0M $3.5M $-2.3M $-125.1M $1.2M $2.0M $886.0K
Net Income $-49.6M $-26.6M $-44.9M $-322.0K $-1.27B $-789.4M $-85.3M $-39.2M
Net Margin -17.6% -12.9% -20.7% -0.2% -566.9% -424.9% -40.5% -19.6%
EPS (Basic) $-0.44 $-0.24 $-0.41 $0.00 $-14.84 $-8.69 $-0.99 $-0.04
EPS (Diluted) $-0.44 $-0.24 $-0.41 $0.00 $-14.84 $-8.69 $-0.99 $-0.04
Shares Outstanding (Basic) 111.8M 112.7M 110.3M 1.06B 89.0M 90.8M 86.5M 875.4M
Shares Outstanding (Diluted) 111.8M 112.7M 110.3M 1.06B 89.0M 90.8M 86.5M 875.4M
Dividends Per Share
← Newer Page 1 of 6 Older →